.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Deloitte
Baxter
Cipla
McKinsey
Moodys
QuintilesIMS
Healthtrust
Fish and Richardson
Julphar

Generated: June 24, 2017

DrugPatentWatch Database Preview

TIGAN Drug Profile

« Back to Dashboard

Which patents cover Tigan, and when can generic versions of Tigan launch?

Tigan is a drug marketed by Par Sterile Products and King Pharms Llc and is included in two NDAs.

The generic ingredient in TIGAN is trimethobenzamide hydrochloride. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the trimethobenzamide hydrochloride profile page.

Summary for Tradename: TIGAN

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list5
Bulk Api Vendors: see list44
Clinical Trials: see list2
Patent Applications: see list230
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TIGAN at DailyMed

Pharmacology for Tradename: TIGAN

Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
TIGAN
trimethobenzamide hydrochloride
INJECTABLE;INJECTION017530-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
King Pharms Llc
TIGAN
trimethobenzamide hydrochloride
CAPSULE;ORAL017531-006Dec 13, 2001ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Deloitte
Novartis
Dow
Chinese Patent Office
McKesson
Boehringer Ingelheim
Fuji
Express Scripts
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot